DISEASE PROGRESSION
KEYTRUDA does not control cancer in all people indefinitely. Sometimes, it does not have an effect at all. If your disease has progressed while on KEYTRUDA, you and your doctor will decide what the next step should be.
ABOUT KEYTRUDA
RESETTING THE COURSE AFTER KEYTRUDA
Your doctor will go through the options available to you. Consider the positives and negatives of each option carefully. Don’t rush your decision, and don’t hesitate to seek a second medical opinion. Your doctor will not be upset.
References
Cancer Council Australia. 2021. Understanding Immunotherapy, A guide for people affected by cancer. Available at: www.cancer.org.au/assets/pdf/understanding-immunotherapy-fact-sheet. Accessed September 2023.
For further information about your condition or treatment consult your healthcare professional or refer to the Consumer Medicine Information for KEYTRUDA.
AU-KEY-00463. Issued September 2023.
MSD Medical Information or to report product complaints (including adverse events): 1800 818 553
This educational website is sponsored by Merck Sharp & Dohme (Australia) Pty Ltd. Information displayed on this website is only intended for Australian residents who are 18 years or older and are currently being treated with KEYTRUDA and as such, its contents have been designed to comply with Australian laws and regulations. The information on this website is educational only and is not intended to be used for any self-diagnosis purposes nor to replace the advice of your Doctor or healthcare professional. Please consult your Doctor or healthcare professional for further information on KEYTRUDA. Use and access of this website is subject to the terms and conditions set out in our Legal Agreement and Privacy Policy.
Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
Merck Sharp & Dohme (Australia) Pty Limited. Level 1 – Building A, 26 Talavera Road, Macquarie Park NSW 2113.
AU-KEY-00559. Issued March 2024.
